The Online Investor
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
NK Buyback image

NantKwest Inc. Buyback

OLI recorded this information on 11/12/2015

Company: NantKwest Inc.
Buyback: NK buyback
$Amount Authorized: $50,000,000
Buyback Details: NantKwest Inc. (NASDAQ:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases, announced today that its Board of Directors has authorized a stock repurchase program under which the company may repurchase up to $50 million of its outstanding common stock.

NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer (NK) cell to treat cancer and viral infectious diseases. NK cells are the body's first line of defense due to their innate ability to seek and destroy abnormal cells, such as cancer or virally infected cells, without prior exposure or activation by other support molecules required to train and activate adaptive immune cells such as T-Cells. Co. holds the exclusive right to commercialize activated NK cells, a commercially viable natural killer cell line, and a range of genetically modified derivatives capable of killing cancer and virally infected cells.
Open the NK Page at The Online Investor »

Company Name:  ImmunityBio Inc
Stock buyback:  NK buyback
Website:  www.nantkwest.com
Sector:  Biotechnology
 

Open the NK Page at The Online Investor (in a new window) »

March 28, 2024    2:53 PM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree NK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
91st percentile
(ranked higher than approx. 91% of all stocks covered)

Analysts' Target Price:
NK Stock Forecast

Based on Zacks ABR data;
powered by Xignite

NK Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.